Physician

Pathology

Richard Sagebiel is an expert in the field of Pathology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Richard Sagebiel is a published doctor and has 101 publications published. The lastest was: 'Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.'

Publications

---

• Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration.
• A patient-centered methodology that improves the accuracy of prognostic predictions in cancer.
• The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.
• Analysis of sentinel lymph node positivity in patients with thin primary melanoma.
• Sunbeds and sunlamps: who used them and their risk for melanoma.
• Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
• A multimarker prognostic assay for primary cutaneous melanoma.
• A multi-marker assay to distinguish malignant melanomas from benign nevi.
• Novel role for RGS1 in melanoma progression.
• Osteopontin as a molecular prognostic marker for melanoma.
• Reproductive risk factors for cutaneous melanoma in women: a case-control study.
• Prognostic significance of extent of ulceration in primary cutaneous melanoma.
• Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
• Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
• Genes and pathways downstream of telomerase in melanoma metastasis.
• Persistent microscopic primary melanoma in patients presenting with node-positive disease.
• Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.
• The role of microsatellites as a prognostic factor in primary malignant melanoma.
• The gene expression signatures of melanoma progression.
• Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
• Diet and melanoma in a case-control study.
• NF-kappa B in the vascular progression of melanoma.
• Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma.
• Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.
• Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.
• Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
• The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy.
• Pathology-important advances in clinical medicine: prognostic features and the management of cutaneous malignant melanoma.
• Outpatient combination chemoimmunotherapy for patients with metastatic melanoma. Results of a phase I/II trial.
• PRIMARY CARCINOMA OF THE LIVER IN RELATION TO CIRRHOSIS.
• Medicine in the life and letters of Samuel Johnson.status of medicine in the eighteenth century.
• Medicine in the life and letters of Samuel Johnson. II. Dr. Johnson''s personal ailments.
• Vascular involvement in the prognosis of primary cutaneous melanoma.
• Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma.
• Evaluation of sentinel lymph node status in spindle cell melanomas.
• Fine needle aspiration in the diagnosis of metastatic melanoma.
• Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
• Pigmented lesion pathology: the specimen and its report. A personal and probably biased approach.
• Inter-observer variability among pathologists'' evaluation of malignant melanoma: effects upon an analytic study.
• Who needs zebras? Comments on desmoplastic melanoma.
• Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic mela...
• Optimal selective sentinel lymph node dissection in primary malignant melanoma.
• Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
• The multidisciplinary melanoma center.
• Unusual variants of melanoma: fact or fiction?
• Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.
• The inheritance pattern of dysplastic naevi in families of dysplastic naevus patients.
• Familial and cutaneous features of dysplastic nevi: a case-control study.
• Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
• Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory.
• Cutaneous malignant melanoma--the party line and more--with a word on "safe sun".
• A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi.
• Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician.
• The pathology of melanoma as a basis for prognostic models: the UCSF experience.
• Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
• Melanoma risk factors and atypical moles.
• Problems in microstaging of melanoma vertical growth.
• Differential diagnosis of Kaposi's sarcoma.
• Melanoma surveillance and earlier diagnosis.
• Sunburns, melanoma, and the pediatrician.
• "Doing things right": approach to the cutaneous pigmented lesion.
• The dysplastic melanocytic nevus.
• Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory.
• The histopathology of dysplastic nevi. Continued controversy.
• Discordance of risk factors for invasive and non-invasive melanoma.
• Early melanoma. Histologic terms.
• Melanoma predicted by clinically atypical moles.
• Biopsy of the cutaneous pigmented lesion.
• Histopathology of borderline and early malignant melanomas.
• Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.
• Cytologic detection of recurrent vaginal melanoma.
• Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.
• The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma.
• Limited Wegener's granulomatosis. Report of a case with oral, renal, and skin involvement.
• Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
• Prenatal diagnosis of congenital bullous ichthyosiform erythroderma (epidermolytic hyperkeratosis) by fetal skin biopsy.
• Plasmapheresis and immunosuppressive drug therapy in scleroderma.
• Kaposi's sarcoma in young homosexual men: a histopathologic study with particular reference to lymph node involvement.
• Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival.
• Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets.
• Giant congenital melanocytic nevus: quantification of nevus debulking after split-thickness excision.
• The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.
• Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma.
• Pigmented spindle cell nevus. Clinical and histologic review of 90 cases.
• Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma.
• Malignant eccrine poroma. Case report and review of the literature.
• Epidermolytic hyperkeratosis: ultrastructure and biochemistry of skin and amniotic fluid cells from two affected fetuses and a newborn infant.
• Prevalence of dysplastic naevi in a community practice.
• Rheumatoid nodules simulating basal-cell carcinoma.
• Non-specific inclusions in epidermal cells of keratoacanthoma.
• Serial reconstruction of the characteristic granule of the Langerhans cell.
• Cutaneous lesions of Fabry''s disease: glycolipid lipidosis; light and electron microscopic findings.
• Fine structural findings in recurrent oral ulceration.
• Multiple cell origin of hereditary neurofibromas.
• In vivo and in vitro uptake of ferritin by Langerhans cells of the epidermis.
• Pseudoxanthoma elasticum. An underdiagnosed genetically heterogeneous disorder with protean manifestations.
• Ultrastructural observations on epidermal cells in Paget''s disease of the breast.
• Histologic artifacts of benign pigmented nevi.
• Oral epithelial dendritic cells of the Rhesus monkey--histologic demonstration, fine structure and quantitative distribution.
• Age distribution and histologic patterns of dysplastic nevi.

Schools

---

• Harvard Medical School

• King Co Hospital

• Massachusetts General Hospital

Doctors Specialties

---

• Dermatopathology
• Pathology

Accepted Insurances

---

Education

---

• Massachusetts General Hospital
• Harborview Medical Center
• Harvard Medical School

Hospital

---

• California Pacific Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Richard G. Glogau, MD This Doctor is OpenDoctor Recommended.
	Dr. Walter E. Finkbeiner, MD This Doctor is OpenDoctor Recommended.
	Dr. John C. Moretto, MD This Doctor is OpenDoctor Recommended.
	Dr. Lamia M. Shagrun, MD This Doctor is OpenDoctor Recommended.
	Dr. Patrick A. Treseler, MD This Doctor is OpenDoctor Recommended.
	Dr. Zuoqin Tang, MD This Doctor is OpenDoctor Recommended.
	Dr. Beth E. Siverman-Ruben, MD
	Dr. Daniel D. Miller, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog